PDF herunterladen
Thromb Haemost 1993; 69(01): 016-020
DOI: 10.1055/s-0038-1651180
Original Article
Coagulation
Schattauer GmbH Stuttgart

Contribution of Plasma Proteinase Inhibitors to the Regulation of Activated Protein C in Plasma

Richard A Marlar
The Departments of Biochemistry, Pathology and Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado, and Laboratory Services, Denver Veterans Administration Medical Center, Denver, Colorado, USA
,
David C Kressin
The Departments of Biochemistry, Pathology and Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado, and Laboratory Services, Denver Veterans Administration Medical Center, Denver, Colorado, USA
,
Renee M Madden
The Departments of Biochemistry, Pathology and Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado, and Laboratory Services, Denver Veterans Administration Medical Center, Denver, Colorado, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 06. Dezember 1990

Accepted after revision 18. August 1992

Publikationsdatum:
04. Juli 2018 (online)

  als PDF herunterladen  Lizenzen und Reprints

Summary

Activated protein C (APC), a serine protease, is regulated in plasma by protease inhibitors. This study was undertaken to determine the role of the major plasma inhibitors in regulating APC in plasma. Kinetic analysis and specific immunoassays for APC-inhibitor complexes were used to determine the inhibitors that form complexes with APC. Of the eight plasma inhibitors investigated, four interact with APC: protein C inhibitor (PCI), α1-proteinase inhibitor (PI), α2-antiplasmin (AP) and C1 esterase inhibitor (C1 Inh). The second order rate constants are: 1.3 × 104 M−1 s−1 (PCI); 15 M−1 s−1 (PI); 410 M−1 s−1 (AP); and <6 M−1 s−1 (C1 Inh), with a relative effectiveness of each inhibitor to inactivate APC in plasma: 49:36:15:<1, respectively. PCI, PI and AP are the major inhibitors of APC in plasma. Low concentrations of APC will be inhibited by PCI with PI and AP playing a secondary role. However, as increasing APC is generated, PI and AP begin to play more important roles as the PCI is consumed.

 

  • References

  • 1 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746
    PubMedGoogle Scholar
  • 2 van Hinsberg VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator inhibitor activity in endothelial cell conditioned media. Blood 1985; 65: 444-451
    PubMedGoogle Scholar
  • 3 de Fouw MJ, Haverkate F, Bertina RM, Kopman J, van Wijngaarden A, van Hinsberg VWM. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood 1986; 67: 1189-1193
    PubMedGoogle Scholar
  • 4 Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983; 258: 163-168
    PubMedGoogle Scholar
  • 5 Heeb MJ, Griffin JH. Physiologic inhibition of human activated protein C by α1-antitrypsin. J Biol Chem 1988; 263: 11613-11617
    PubMedGoogle Scholar
  • 6 van der Meer RJM, van Tilburg NH, van Wijngaarden A, van der Linden IK, Briët E, Bertina RM. A second plasma inhibitor of activated protein C: α1-antitrypsin. Thromb Haemostas 1989; 62: 756-762
    PubMedGoogle Scholar
  • 7 Heeb MJ, Espana F, Griffin JH. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood 1989; 73: 446-454
    CrossrefPubMedGoogle Scholar
  • 8 Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 1980; 66: 1186-1189
    CrossrefPubMedGoogle Scholar
  • 9 Suzuki K, Nishioka J, Kusumoto H. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem 1984; 95: 187-195
    CrossrefPubMedGoogle Scholar
  • 10 Suzuki K. Activated protein C inhibitor. Semin Thromb Hemostas 1984; 10: 154-161
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 11 Heeb MJ, Espana F, Geiger M, Collen D, Stump DC, Griffin JH. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem 1987; 262: 15813-15816
    PubMedGoogle Scholar
  • 12 Bao J, Sifers RN, Kidd JV, Ledley FD, Wo SLC. Molecular evolution of serpins: homologous structure of the human α1-antichymotrypsin and α1-antitrypsin genes. Biochemistry 1987; 26: 7755-7759
    CrossrefPubMedGoogle Scholar
  • 13 Suzuki K, Nishioka J, Hashimoto S, Kamiya T, Saito H. Normal titer of functional and immunoreactive protein C inhibitor in plasma of patients with congenital combined deficiency of factor V and factor VIII. Blood 1983; 62: 1266-1270
    PubMedGoogle Scholar
  • 14 Meijers JCM, Kanters DHAJ, Vlooswijk RAA, van Erp HE, Hessing M, Bouma BN. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 1988; 27: 4231-4235
    CrossrefPubMedGoogle Scholar
  • 15 Travis J, Johnson D. Human α1-proteinase inhibitor. In: Proteolytic Enzymes. Lorand L. (ed). Meth Enzymol 1981. 80 754-765
    Google Scholar
  • 16 Downing MR, Bloom JW, Mann KG. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry 1978; 17: 2649-2653
    CrossrefPubMedGoogle Scholar
  • 17 Gitel SN, Medina VM, Wessler S. Inhibition of human activated factor X by antithrombin III and α1-proteinase inhibitor in human plasma. J Biol Chem 1984; 259: 6890-6892
    PubMedGoogle Scholar
  • 18 Marlar RA, Kressin DC. Activated protein C inhibition in plasma. Blood 1987; 70: 367a
    PubMedGoogle Scholar
  • 19 Marlar RA, Endres-Brooks J, Miller C. Serial studies of protein C and its inhibitor in patients with disseminated intravascular coagulation. Blood 1985; 66: 59-63
    PubMedGoogle Scholar
  • 20 Chase T, Shaw E. Titration of trypsin, plasmin, and thrombin with p-Nitrophenyl p’-Guanidinobenzoate HCl. Meth Enzymol 1970; 19: 20-27
    PubMedGoogle Scholar
  • 21 Fair DS, Marlar RA. Biosynthesis and secretion of factor VII, protein C, protein S and the protein C inhibitor from a human hepatoma cell line. Blood 1986; 67: 64-70
    PubMedGoogle Scholar
  • 22 Wiman B. Human α2-antiplasmin. In: Proteolytic Enzymes. Lorand L. (ed). Meth Enzymol 1981. 80 395-408
    Google Scholar
  • 23 Sim RB, Reboul A. Preparation and properties of human C1 inhibitor. In: Proteolytic Enzymes. Lorand C. (ed). Meth Enzymol. 1981. 80 43-54
    Google Scholar
  • 24 Laurell M, Carlson TH, Stenflo J. Monoclonal antibodies against the heparin-dependent protein C inhibitor suitable for inhibitor purification and assay of inhibitor complexes. Thromb Haemostas 1988; 60: 334-339
    PubMedGoogle Scholar
  • 25 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 . Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 26 Weber K, Osborn M. The reliability of molecular weight determination by dodecylsulfate-polyacrylamide gel electrophoresis. J Biol Chem 1969; 244: 4406-4412
    PubMedGoogle Scholar
  • 27 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some application. Proc Natl Acad Sci USA 1979; 76: 4350-4354
    CrossrefPubMedGoogle Scholar
  • 28 Harpel P. α2-plasmin inhibitor and α2-macroglobulin-plasmin complexes in plasma. J Clin Invest 1981; 68: 46-55
    CrossrefPubMedGoogle Scholar
  • 29 BioRad. DEAE affi-gel blue affinity media purifies IgG. Manufacturers Techn Bull. 1968 No 1062
    PubMedGoogle Scholar
  • 30 Knight LC, Budzynski AZ, Olexa SA. Radiolabelling of fibrinogen using the iodogen technique. Thromb Haemostas 1981; 46: 593-596
    PubMedGoogle Scholar
  • 31 Greffe BS, Manco-Johnson MJ, Marlar RA. Molecular forms of human protein C: Comparison and distribution in human plasma. Thromb Haemostas 1989; 62: 902-905
    PubMedGoogle Scholar
  • 32 Heeb MJ, Gruber A, Griffin JH. Identification of divalent metal iondependent inhibition of activated protein C by α2-macroglobulin and α2-antiplasmin in blood and comparisons to inhibition of factors Xa, thrombin and plasmin. J Biol Chem 1991; 266: 17606-17612
    PubMedGoogle Scholar
  • 33 Jane SM, Mitchell CA, Hau L, Salem HH. Inhibition of activated protein C by platelets. J Clin Invest 1989; 83: 222-226
    CrossrefPubMedGoogle Scholar
  • 34 Friedberg RC, Hagen PO, Pizzo SV. The role of endothelium in factor Xa regulation: the effect of plasma proteinase inhibitors and hirudin. Blood 1988; 71: 1321-1328
    PubMedGoogle Scholar
  • 35 Fuchs HE, Trapp HG, Griffith MJ, Roberts HR, Pizzo SV. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse: Role of the endothelium and the plasma proteinase inhibitors. J Clin Invest 1984; 73: 1696-1703
    CrossrefPubMedGoogle Scholar
  • 36 Rakoczi I, Wiman B, Collen D. On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin. Biochim Biophys Acta 1978; 540: 295-350
    CrossrefPubMedGoogle Scholar
  • 37 Marcum JA, Rosenberg RD. Anticoagulantly active heparan sulfate proteoglycan and the vascular endothelium. Semin Thromb Hemostas 1987; 13: 464-474
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 38 Heeb MJ, Mosher D, Griffin JH. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood 1989; 73: 455-460
    PubMedGoogle Scholar
  • 39 Harris KW, Esmon CT. Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 1985; 260: 2007-2010
    PubMedGoogle Scholar
  • 40 Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072
    PubMedGoogle Scholar
  • 41 Walker FJ. Regulation of activated protein C by protein S. J Biol Chem 1981; 256: 11128-11132
    PubMedGoogle Scholar
  • 42 Teitel JM, Rosenberg RD. Protection of factor Xa from neutralization by the heparin-antithrombin complex. J Clin Invest 1983; 71: 1383-1391
    CrossrefPubMedGoogle Scholar